The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Karyopharm Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Novel bone anabolic for cancer bone metastasis (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen
DREAMM-2: Assessing efficacy via indirect comparison of single-agent belantamab mafodotin versus selinexor plus dexamethasone combination in anti-CD38 exposed relapsed/refractory multiple myeloma (RRMM).
 
Rakesh Popat
Honoraria - Celgene; GlaxoSmithKline; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda
 
Attaya Suvannasankha
No Relationships to Disclose
 
Venediktos Kapetanakis
Employment - Evidera
 
Thibaud Prawitz
Employment - Evidera
 
Grammati Sarri
Employment - Evidera
 
Rachel Hughes
No Relationships to Disclose
 
Feng Wang
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb
Research Funding - GlaxoSmithKline (Inst)
 
Cosima Hogea
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Research Funding - GlaxoSmithKline
 
Shannon Allen Ferrante
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Merck
 
Jenny Willson
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline